Sterling Investment Advisors, Ltd. Adc Therapeutics Sa Transaction History

Sterling Investment Advisors, Ltd.

  • $370 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 02, 2022
BUY
$19.29 - $31.51 $21,219 - $34,661
1,100 New
1,100 $22,000
Q3 2020

Oct 26, 2020
SELL
$32.87 - $51.05 $32,870 - $51,050
-1,000 Closed
0 $0
Q2 2020

Jul 24, 2020
BUY
$29.65 - $46.81 $29,650 - $46,810
1,000 New
1,000 $46,000

Others Institutions Holding ADCT

# of Institutions
79
Shares Held
55M
Call Options Held
82.7K
Put Options Held
31.5K
View Full List

About ADC Therapeutics SA

ADCT Quotes by TradingView
  • Ticker ADCT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,645,296
  • Market Cap $155M
  • Description
  • ADC Therapeutics SA, a commercial-stage biotechnology company, develops antibody drug conjugates (ADC) for patients suffering from hematological malignancies and solid tumors. Its flagship product ZYNLONTA that is in Phase II clinical trial for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma;...
More about ADCT
Track This Portfolio

Track Sterling Investment Advisors, Ltd. Portfolio

Follow Sterling Investment Advisors, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sterling Investment Advisors, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Sterling Investment Advisors, Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email